oxociprofloxacin has been researched along with Kidney Failure, Chronic in 1 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bren, A; Drinovec, J; Karba, R; Kozjek, F; Mrhar, A; Primozic, S; Varl, J | 1 |
1 other study(ies) available for oxociprofloxacin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 1989 |